Luye Pharma Stock

Detail Data
Volume (24h): 187,407,500 shares
P/E Ratio: 18.00
Forward P/E: 9.33
EPS: 0.14 HKD
Forward EPS: 0.27 HKD
Number of Shares: 3,761,669,888 shares
Market Capitalization: 9,479,407,616.00 HKD

Dividend

Dividend Value
Dividend Amount According to our data, the company Luye Pharma does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: 2020-06-29
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: 0.06 HKD
Last Dividend Date: 2020-06-29

Analyst Forecast

Most analysts have issued a none recommendation for Luye Pharma stock. The current number of analysts covering this company is 3. The highest target price is 3.1525855 HKD, while the lowest target price is 2.0258846 HKD. The median target valuation set by analysts is 2.479831 HKD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Luye Pharma.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Luye Pharma stock is: none
Number of Analysts: 3
Highest Target Price: 3.1525855 HKD
Lowest Target Price: 2.0258846 HKD
Median Target Price: 2.479831 HKD

Fundamental Indicators

Indicator Data
Total Revenue: 6,061,441,024.00 HKD
Net Income: 471,886,016.00 HKD
Price-to-Book (P/B): 0.67
PEG Ratio: /
Exchange: HKSE
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Number of Employees: 5234
Country: China

Where to Buy Luye Pharma Stock?

You can purchase Luye Pharma stock on the HKSE under the ticker symbol: 2186.HK. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Luye Pharma Stock

Indicator Value
Company Revenue: 6,061,441,024.00 HKD
EBITDA: 1,891,572,992.00 HKD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share: 0.14 HKD
Book Value Per Share: 3.76 HKD
Total Cash: 6,503,212,032.00 HKD
Total Cash per Share: 1.73 HKD
Total Debt: 10,321,053,696.00 HKD
Debt to Equity Ratio: 0.66
Quick Ratio 1.01
Current Ratio 1.24
Free Cash Flow -2,501,444,096.00 HKD
Operating Cash Flow 167,764,000.00 HKD
Gross Margins 66.72 %
EBITDA Margins 31.21 %
Operating Margins 17.81 %
Profit Margins 7.79 %
Return on Assets 2.6 %
Return on Equity 4.4 %
Earnings Growth (1 year) -78.1%
Revenue Growth (1 year) -7.8 %
Quarterly Earnings Year-over-Year Growth -78.0 %
Market Capitalization 9,479,407,616.00 HKD
Enterprise Value 14,896,393,216.00 HKD
EV/Revenue 2.458
EV/EBITDA 7.875
Float Shares 1,963,253,525 shares
Shares Outstanding 3,761,669,888 shares
Held Percent Insiders 0.33 %
Held Percent Institutions 29.96 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 0.79
Short Percentage of Float -
Implied Shares Outstanding 3,761,669,888

Frequently Asked Questions (FAQ)

According to our data, the company Luye Pharma does not pay dividends yet, even in 2025.

Luye Pharma shares are traded on the HKSE stock exchange under the ticker: 2186.HK. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for Luye Pharma shares is from a total of 3 analysts. The average target price prediction is 2.479831 HKD per share.

The total number of Luye Pharma shares on the exchange is 3,761,669,888.00 shares, which at the current market capitalization gives the company a total valuation of 9,479,407,616.00 HKD.